Research programme: casein kinase 2 inhibitors - Kyoto University/Toray/Tokyo Womens Medical UniversityAlternative Names: Casein kinase 2 inhibitors research programme - Kyoto University/Toray/Tokyo Womens Medical University
Latest Information Update: 28 Aug 2007
At a glance
- Originator Kyoto University; Tokyo Medical University; Toray
- Mechanism of Action Phosphotransferase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Nephritis
Most Recent Events
- 03 Jun 2005 Preclinical trials in Nephritis in Japan (unspecified route)